Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Atenurix - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Atenurix

Approved

STANDARD

Atenurix

Ajanta Pharma Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: f1e80a6a08afd439
Company: Ajanta Pharma Limited
Type: Standard

Approval Details

Approval Id: f1e80a6a08afd439
Drug Approval Philippines Name: Atenurix
Product Name: Atenurix
Registration Number: DRP-12170
Brand Name: Atenurix
Generic Name: Febuxostat
Dosage Form: Film-Coated Tablet
Dosage Strength: 80mg
Manufacturer: Ajanta Pharma Limited
Importer: Ajanta Pharma Philippines Inc
Distributor: Ajanta Pharma Philippines Inc
Company Detail Path: /organization/ajanta-pharma-limited
Issuance Date: 28 June 2022
Expiry Date: 28 June 2027
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

f1e80a6a08afd439

Type

Standard

Back to Philippines FDA Approvals